Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ACLX | ACAD | MOR | ||
Company | Arcellx Inc | Acadia Pharmaceutica | Morphosys Ag ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 54.69 | 17.44 | 17.86 | ||
High | 55.85 | 17.58 | 17.93 | ||
Low | 52.37 | 17.03 | 17.80 | ||
Last | 52.69 | 17.05 | 17.89 | ||
Change | -0.60 | -0.03 | +0.02 | ||
% Change | -1.13% | -0.18% | +0.11% | ||
Volume | 402,900 | 1,160,200 | 458,700 | ||
20-Day Average Volume | 476,885 | 1,457,495 | 627,955 | ||
Previous Close | 53.29 | 17.08 | 17.87 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 54.62 | 17.08 | 17.94 | ||
20-Day Raw Stochastic | 23.06% | 42.69% | 73.28% | ||
20-Day Relative Strength | 39.56% | 37.92% | 56.30% | ||
Weighted Alpha | +2.94 | -45.04 | +68.07 | ||
Today's Opinion | 8% Sell | 100% Sell | 48% Buy | ||
Previous Opinion | 8% Sell | 100% Sell | 56% Buy | ||
Last Month's Opinion | 56% Buy | 100% Sell | 100% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +1.48% since 04/26/24 | +2.03% since 04/26/24 | -0.83% since 04/26/24 | ||
Low | 49.81 on 04/30/24 | 16.50 on 04/30/24 | 17.04 on 04/29/24 | ||
High | 55.85 on 05/03/24 | 17.58 on 05/03/24 | 17.95 on 05/02/24 | ||
1-Month | |||||
%Chg | -16.63% since 04/03/24 | -7.44% since 04/03/24 | -1.16% since 04/03/24 | ||
Low | 49.66 on 04/25/24 | 16.16 on 04/25/24 | 17.04 on 04/29/24 | ||
High | 64.49 on 04/04/24 | 18.63 on 04/04/24 | 18.20 on 04/09/24 | ||
3-Month | |||||
%Chg | -17.08% since 02/02/24 | -32.58% since 02/02/24 | +61.61% since 02/02/24 | ||
Low | 49.66 on 04/25/24 | 16.16 on 04/25/24 | 11.06 on 02/05/24 | ||
High | 75.10 on 03/07/24 | 26.78 on 02/12/24 | 18.31 on 03/12/24 | ||
6-Month | |||||
%Chg | +18.06% since 11/03/23 | -29.16% since 11/03/23 | +125.60% since 11/03/23 | ||
Low | 43.50 on 11/10/23 | 16.16 on 04/25/24 | 4.18 on 11/22/23 | ||
High | 75.10 on 03/07/24 | 32.59 on 12/22/23 | 18.31 on 03/12/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 2,807,850 | 2,816,711 | 2,694,610 | ||
Shares Outstanding, K | 53,290 | 165,203 | 150,621 | ||
Annual Sales | 110,320,000 | 726,440,000 | 257,890,000 | ||
Annual Net Income | -70,690,000 | -61,290,000 | -205,350,000 | ||
Last Quarter Sales | 63,150,000 | 231,040,000 | 63,610,000 | ||
Last Quarter Net Income | 19,840,000 | 45,800,000 | 53,170,000 | ||
60-Month Beta | 0.24 | 0.42 | 1.15 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.42 on 02/28/24 | 0.28 on 02/27/24 | -2.24 on 04/29/24 | ||
Latest Earnings Date | 05/13/24 | 05/08/24 | 05/01/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |